GH1 and Bloom syndrome: In recent years, recombinant human GH (rhGH) treatment has been introduced in several syndromic disorders with short stature, regardless of their GH status, while in some syndromes, such as Bloom syndrome which has high rate of chromosomal breakage and a high risk of malignancy, rhGH has not been advocated (1).